Tag:

CRO

Latest Headlines

Latest Headlines

Tips for a successful relationship with a CRO

More and more device companies are turning to contract research organizations for assistance in managing their clinical trials, something that is commonplace in the biopharma world. The first ever Partnerships in Medical Device Trials Conference was recently held in Chicago.

CROs are spending more on merit raises, survey says

On the whole, the CRO industry is increasing its budgets for merit-based pay increases, according to a survey.

Analyst: CROs like Covance and Icon will take the lead on IT and genomics

With the spiraling amount of time and money needed to bring a drug to market weighing heavy on their Big Pharma clients, CROs have invested in efficiency boosting technology to gain a competitive edge. And the trend is tipped to continue, with an analyst predicting CROs will be at the forefront of developments in IT and genomics in 2014.

U.K. biotech PolyTherics scores $20.1M in funding for Antitope merger

PolyTherics and Antitope have completed a merger of their equally sized biopharma services businesses in the U.K., seeking to provide technology and support to the pack of drugmakers in the hunt for biologics such as antibody-drug conjugates.

New trial search engine steps into congested market

Another clinical trial search engine rolled out this week with talk of making it easier for patients to find studies, and vice versa. But the website, MyClinicalTrialLocator, finds itself in an increasingly congested market filled with CROs, in-house Big Pharma platforms and niche players.

CRO buys chunk of mobile outfit behind virtual Pfizer trial

Mytrus has found a new patron as the startup advances mobile apps for clinical trials. InVentiv Health, a contract research organization (CRO) for pharma and device companies, has snapped up an equity stake in Mytrus and plans to partner on commercializing the startup's mobile apps.

Quintiles files for $600M IPO

Quintiles made it official on Feb. 15, filing to raise up to $600 million in an IPO after months of rumors and speculation.

UPDATED: Global CRO Quintiles plans to raise up to $600M in IPO

Remember those rumors back in January about a big Quintiles IPO? Somebody had some good information. The global CRO filed its S-1 with the SEC this afternoon, outlining plans to go public in one of the biggest new industry offerings in quite some time.

GoBalto lands major pharma CRO as customer for cloud software

INC Research has signed on to use goBalto's web-based software to boost the process of getting clinical trials up and running, providing the Bay Area startup with what appears to be one of its biggest customer wins yet for the tech.

Piramal continues market access blitz with Abacus takeover

Piramal Healthcare has accelerated its move into market access modeling by snapping up U.K. firm Abacus International for an undisclosed fee. The takeover comes months after India-based Piramal jumped into the sector by snagging Decision Resources Group for $635 million.